Establishment Labs Holdings (ESTA) Other financing activities (2017 - 2018)
Establishment Labs Holdings' quarterly Other financing activities came in at -$81000.0 in Q3 2018, down 112.98% year-on-year from $624000.0 in Q3 2017, and down 112.98% quarter-over-quarter from $624000.0 in Q3 2017.
Establishment Labs Holdings has reported Other financing activities for 2 years, with the latest figure at -$81000.0 in Q3 2018.
- For the quarter ending Q3 2018, Other financing activities fell 112.98% year-over-year to -$81000.0; the trailing twelve-month figure through Dec 2018 stood at $543000.0 (changed N/A YoY), and the FY2017 full-year result was $914000.0, changed N/A from the prior year.
- Other financing activities for Q3 2018 stood at -$81000.0, down from $624000.0 in the prior quarter.
- The five-year high for Other financing activities was $624000.0 in Q3 2017, with the low at -$81000.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -81,000.00 |
| Sep 30, 2018 | -81,000.00 |
| Sep 30, 2017 | 624,000.00 |
| Sep 30, 2017 | 624,000.00 |